{"id":897,"date":"2026-10-20T03:13:09","date_gmt":"2026-10-20T01:13:09","guid":{"rendered":"http:\/\/novameds.local\/es\/?post_type=product&#038;p=897"},"modified":"2026-10-20T03:59:39","modified_gmt":"2026-10-20T01:59:39","slug":"catalog-clomiphene-1500mg-25mg-capsule","status":"publish","type":"product","link":"https:\/\/novameds.health\/es\/producto\/catalog-clomiphene-1500mg-25mg-capsule\/","title":{"rendered":"Clomiphene, 1500mg (25mg\/capsule)"},"content":{"rendered":"<section id=\"composition\" data-nav=\"Composici\u00f3n y detalles del producto\">\n<h2>Composici\u00f3n y detalles del producto<\/h2>\n<div class=\"nm-catalog-document\">\n<div>\n<h2>Descripci\u00f3n<\/h2>\n<div>\n<p>Clomiphene is a racemic mixture of two geometric isomers of a triphenylethylene selective oestrogen receptor modulator (SERM): enclomiphene (trans-isomer, predominant ER antagonist) and zuclomiphene (cis-isomer, mixed ER agonist\/antagonist). The racemic mixture has a well-characterised clinical pharmacological profile as a SERM used to investigate hypothalamic\u2013pituitary\u2013gonadal axis feedback.<\/p>\n<p>Research applications include SERM pharmacology, HPG-axis feedback investigation, and isomeric mixture vs. isolated isomer comparative studies.<\/p>\n<ul>\n<li> <span><b>High Purity<\/b> \u2013 99% Purity Guaranteed<\/span><\/li>\n<li> Independently Lab Tested<\/li>\n<li> Research Grade Quality<\/li>\n<li> For Laboratory Research Use Only<\/li>\n<\/ul><\/div>\n<div>\n<p><a href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/60974\" target=\"_blank\" rel=\"noopener noreferrer\">Datos moleculares en PubChem<\/a><\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<h2>Propiedades<\/h2>\n<div class=\"nm-catalog-table\" tabindex=\"0\" role=\"region\" aria-label=\"Product data\">\n<table>\n<tbody>\n<tr>\n<th>Chemical Formula<\/th>\n<td>C32H36ClNO8<\/td>\n<\/tr>\n<tr>\n<th>Synonyms<\/th>\n<td>Clomiphene citrate salt, 2-(4-[2-Chloro-1,2-diphenylethenyl]phenoxy)-N,N-diethylethanamine, Clostilbegit, Dyneric, Klostilbegit, Serophene<\/td>\n<\/tr>\n<tr>\n<th>Molar Mass<\/th>\n<td>598.1 g\/mol<\/td>\n<\/tr>\n<tr>\n<th>CAS Number<\/th>\n<td>50-41-9<\/td>\n<\/tr>\n<tr>\n<th>PubChem CID<\/th>\n<td>60974<\/td>\n<\/tr>\n<tr>\n<th>Total Compound Content<\/th>\n<td>1,500 mg (25 mg per capsule)<\/td>\n<\/tr>\n<tr>\n<th>Shelf Life<\/th>\n<td>36 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n<div>\n<h2>Investigaci\u00f3n<\/h2>\n<p>\t\t\t\t\t<span>Clomiphene is a synthetic triphenylethylene compound supplied as a racemic mixture of two geometric isomers: enclomiphene (~38% of mixture; trans-isomer, predominantly ER antagonist, t\u00bd ~10 hours) and zuclomiphene (~62% of mixture; cis-isomer, mixed ER agonist-antagonist, t\u00bd ~30 days). The combined profile \u2014 transient ER antagonism from enclomiphene plus prolonged background ER activity from zuclomiphene \u2014 produces a net increase in LH and FSH secretion via hypothalamic-pituitary ER de-repression, though the zuclomiphene accumulation complicates isomer-specific mechanistic attribution. Clomiphene has a long clinical history in reproductive endocrinology, providing extensive pharmacodynamic and safety data. It remains the reference compound for SERM-mediated HPG-axis modulation research, with enclomiphene (separate SKU) available for studies requiring isolated trans-isomer pharmacology without zuclomiphene confound. Supplied in 25 mg capsules. Independently third-party HPLC-tested; COA available per batch.<\/span>\t\t\t\t\t<\/div>\n<div>\n<h2>FAQ<\/h2>\n<div>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What is the isomeric composition of clomiphene and how does it differ from enclomiphene?<\/span><\/p>\n<\/summary>\n<div>\n<p>Clomiphene is a racemic mixture of approximately 38% enclomiphene (trans-isomer) and 62% zuclomiphene (cis-isomer). Enclomiphene is predominantly an ER antagonist with a ~10-hour half-life. Zuclomiphene is a mixed ER agonist\/antagonist with a ~30-day half-life, leading to accumulation with repeated dosing.<\/p>\n<p>SwissChems also supplies isolated enclomiphene (ENCLOMFNE-60) for studies requiring pure trans-isomer pharmacology without the zuclomiphene background.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>Why does zuclomiphene&#8217;s long half-life complicate mechanistic research with clomiphene?<\/span><\/p>\n<\/summary>\n<div>\n<p>Zuclomiphene accumulates with repeated dosing (t\u00bd ~30 days vs. enclomiphene&#8217;s ~10 hours), creating a progressively increasing background of ER agonist\/antagonist activity that is difficult to control or quantify in repeat-dose study designs. This accumulation confounds attribution of pharmacodynamic effects to the enclomiphene component \u2014 the presumed primary active isomer for HPG-axis modulation.<\/p>\n<p>Researchers studying acute or isomer-specific ER antagonism at the HPG axis typically prefer isolated enclomiphene to avoid this confound.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What is clomiphene&#8217;s mechanism of action at the hypothalamic-pituitary axis?<\/span><\/p>\n<\/summary>\n<div>\n<p>Clomiphene&#8217;s primary HPG-axis mechanism is ER antagonism at hypothalamic arcuate nucleus KNDy neurons and pituitary gonadotrophs. Oestrogen-mediated negative feedback normally suppresses GnRH pulsatility and gonadotropin secretion. ER antagonism by clomiphene&#8217;s enclomiphene component reduces this negative feedback, increasing GnRH pulse frequency and downstream LH\/FSH secretion.<\/p>\n<p>The zuclomiphene component provides a counteracting partial ER agonist background that partially offsets this effect, resulting in the net gonadotropin-stimulating profile of the racemic mixture.<\/p>\n<\/div>\n<\/details><\/div>\n<\/p><\/div>\n<div>\n<p>Los excipientes de la c\u00e1psula no se especifican en la documentaci\u00f3n disponible.<\/p>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Clomiphene is a racemic mixture of two geometric isomers of a triphenylethylene selective oestrogen receptor modulator (SERM): enclomiphene (trans-isomer, predominant ER antagonist) and zuclomiphene (cis-isomer, mixed ER agonist\/antagonist).<\/p>\n<p>Presentaci\u00f3n: Clomiphene, 1500mg (25mg\/capsule).<\/p>\n<p class=\"nm-research-disclaimer\">Solo para investigaci\u00f3n de laboratorio. No apto para uso humano o veterinario.<\/p>\n<p class=\"nm-catalog-image-note\"><small>Envase ilustrativo generado con IA.<\/small><\/p>\n","protected":false},"featured_media":1049,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[27],"product_tag":[],"nm_classification":[],"class_list":["post-897","product","type-product","status-publish","has-post-thumbnail","product_cat-longevity-cellular-health","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product\/897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/comments?post=897"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/media\/1049"}],"wp:attachment":[{"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/media?parent=897"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product_brand?post=897"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product_cat?post=897"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product_tag?post=897"},{"taxonomy":"nm_classification","embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/nm_classification?post=897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}